US Backs Oral COVID-19 Therapies And ‘Next Pandemic’ Drug Discovery With $3.2bn

Aims To De-Risk Pandemic R&D

 
• By Andrew McConaghie
  
Anthony Fauci 2021
Anthony Fauci sets out the plan, including new oral antivirals as the immediate priority. Most advanced is Merck's molnupiravir, which could gain an EUA before the end of 2021. • Source: Getty Images

More from Business

More from Scrip